The practical library
Dosing, safety, and metabolic health
Start with the question you want to discuss with your clinician. Each medical guide cites its evidence and shows its review status.
Charts explain a label; they do not choose your dose. For a product-specific question, use your prescription and pharmacist. Our editorial standards.
DosingMounjaro dosage chart: a guide to the labelAdult Mounjaro dosing, titration, missed-dose rules, and the difference between diabetes and weight-management prescribing.DosingZepbound dosage chart: a guide to the labelZepbound's weekly escalation and different maintenance doses for weight management and obstructive sleep apnea.DosingOzempic dosage chart: a guide to the labelOzempic injection doses for diabetes, kidney-risk reduction, and product-specific missed-dose instructions.DosingWegovy injection dosage chart: a guide to the labelWegovy injection titration, indication-specific maintenance, missed doses, and the separate Wegovy HD option.DosingSemaglutide dosage charts: injection and oral productsCompare Ozempic, Wegovy injection, Wegovy tablets, and Rybelsus without mixing up doses or syringe units.DosingWegovy pill dosage chart and daily instructionsThe 1.5 mg, 4 mg, 9 mg, and 25 mg Wegovy tablet schedule, fasting instructions, and missed-dose rule.DosingFoundayo dosage chart: initiation, escalation, and interactionsThe labeled orforglipron titration steps, daily administration, missed tablets, and important dose-limiting interactions.DosingWhere to inject semaglutide: approved sites and techniqueThe labeled injection sites for Ozempic and Wegovy, rotation, device instructions, and why site choice does not guarantee better results.DosingWhere to inject tirzepatide: approved sites and techniqueThe labeled injection sites for Mounjaro and Zepbound, rotation, device instructions, and why site choice does not guarantee better results.DosingBest time to take semaglutide: consistency and label rulesWeekly semaglutide timing, food considerations, changing the dosing day, and the difference between anecdotes and evidence.DosingBest time to take tirzepatide: consistency and label rulesWeekly tirzepatide timing, food considerations, changing the dosing day, and the difference between anecdotes and evidence.DosingWhen to take tirzepatide after travel, a late dose, or a schedule changeApply tirzepatide's 96-hour missed-dose window and 72-hour spacing rule without accidentally doubling treatment.DosingMissed GLP-1 dose guide: rules differ by productCompare late-dose rules for Ozempic, Wegovy injection and tablets, and tirzepatide; plan prolonged restarts with a clinician.
SafetyGLP-1 dosing safety: mg, mL, and syringe unitsWhy dose, concentration, volume, and syringe markings must be kept separate when using a GLP-1 vial.DosingTravel with GLP-1 medicines: storage and schedule checksPrepare for travel by checking the exact product's temperature limits, presentation, supplies, and weekly timing.
AccessBuying semaglutide online: products, prescription, and pharmacy checksA safe access guide to Ozempic, Wegovy injections and tablets, Rybelsus, and compounded semaglutide claims.AccessBuying tirzepatide online: Mounjaro, Zepbound, and sourcingCompare tirzepatide access routes without confusing a compounded product with Mounjaro or Zepbound.AccessHow to compare online semaglutide programsCompare approved-product access, care fees, pharmacy costs, oral options, and follow-up rather than unsupported provider ratings.AccessHow to compare online tirzepatide programsA practical comparison of tirzepatide clinical access, Mounjaro and Zepbound indications, pharmacy sourcing, and total costs.AccessWhere to get tirzepatide: clinic, pharmacy, or access programCompare local care, telehealth, and manufacturer pharmacy routes for tirzepatide with sourcing and continuity checks.AccessCompounding pharmacies for semaglutide: what to verify nowUpdated semaglutide compounding guidance after shortage resolution, with pharmacy, prescription, and dosing checks.AccessCompounding pharmacies for tirzepatide: what to verify nowUpdated tirzepatide compounding guidance after shortage resolution, with pharmacy, prescription, and dosing checks.SafetyCompounded GLP-1 safety and current FDA concernsUnderstand approval status, shortage-era restrictions, salt forms, dosing errors, and why additives do not establish equivalence.AccessGLP-1 cost and insurance: build a complete budgetSeparate care membership, medication, labs, supplies, introductory offers, and prior authorization when comparing GLP-1 treatment.AccessTelehealth GLP-1 checklist: before enrollment and after dispensingA practical checklist for product identity, state-licensed care, pharmacy sourcing, fees, follow-up, and dosing instructions.SafetyWhy can Mounjaro cause diarrhea? Symptoms and when to get helpUnderstand diarrhea during tirzepatide treatment, dehydration concerns, dose escalation, and symptoms needing medical care.SafetySulfur burps on Mounjaro: what is known and what is uncertainSeparate recognized burping and reflux symptoms from unproven sulfur-burp explanations and internet remedies.SafetyGLP-1 side effects: common symptoms and serious warning signsA product-aware guide to digestive side effects, dehydration, hypoglycemia, pancreatitis concerns, and clinical follow-up.SafetyGLP-1 medicines, pregnancy, and oral contraceptionProduct-specific pregnancy planning and the different oral contraceptive precautions for tirzepatide and Foundayo.SafetyGLP-1 medicines before surgery or sedationWhy delayed gastric emptying matters for anesthesia, what information to share, and why a universal hold rule is insufficient.SafetyGLP-1 microdosing: separate marketing from evidenceWhat to ask about low-dose GLP-1 offers, approved starter doses, prevention claims, and formulation-specific evidence.SafetyRetatrutide status: research is not a prescription approvalUnderstand the difference between investigational retatrutide research and unapproved products sold online.
Metabolic healthWeight loss with GLP-1 medicines: evidence and a sustainable care planUnderstand treatment eligibility, mechanism, realistic trial interpretation, nutrition, follow-up, and what can happen after stopping.Metabolic healthBlood tests during GLP-1 care: what each result can tell youA clinician-focused guide to HbA1c, glucose, kidney measures, lipids, and choosing tests by medical need.Metabolic healthStopping GLP-1 treatment: weight regain and continuing careWhat the STEP 1 extension shows about stopping semaglutide, and how to discuss access, follow-up, and restart planning.Metabolic healthNutrition and muscle during GLP-1 weight managementPlan adequate nourishment, activity, and support during reduced appetite without promising a universal protein target or perfect muscle preservation.Metabolic healthGLP-1 heart and kidney benefits: match the label to the patientUnderstand why cardiovascular and kidney-risk reduction belong to specific medicines, indications, and populations.Metabolic healthZepbound and obstructive sleep apnea: the approved roleZepbound's moderate-to-severe OSA indication in adults with obesity, maintenance dosing, and continuing sleep care.Metabolic healthWegovy and MASH: an indication with important limitsWegovy injection's noncirrhotic MASH indication, fibrosis criteria, accelerated approval, and why tablets or HD claims should not be generalized.